Robeco Institutional Asset Management B.V. Grows Position in Healthpeak Properties, Inc. (NYSE:DOC)

Robeco Institutional Asset Management B.V. boosted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 5.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 640,955 shares of the real estate investment trust’s stock after purchasing an additional 31,799 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Healthpeak Properties were worth $12,992,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. State Street Corp purchased a new stake in Healthpeak Properties during the 3rd quarter worth approximately $1,093,576,000. JPMorgan Chase & Co. boosted its holdings in shares of Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after acquiring an additional 4,056,931 shares during the last quarter. Geode Capital Management LLC purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $403,898,000. Charles Schwab Investment Management Inc. purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $175,697,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $20.66 on Friday. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31. The company has a fifty day moving average of $20.75 and a two-hundred day moving average of $21.55. The stock has a market capitalization of $14.45 billion, a PE ratio of 43.96, a P/E/G ratio of 2.18 and a beta of 1.14. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26.

Analyst Ratings Changes

Several research firms have recently commented on DOC. Wells Fargo & Company dropped their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and upped their price objective for the company from $20.00 to $28.00 in a report on Monday, October 21st. Royal Bank of Canada upped their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. StockNews.com cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Finally, Robert W. Baird boosted their target price on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $24.15.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.